The U.S. dried blood spot collection cards market size was estimated at around USD 115.33 million in 2023 and it is projected to hit around USD 169.9 million by 2033, growing at a CAGR of 3.95% from 2024 to 2033.
Dried blood spot (DBS) collection cards are paper-based devices used for collecting small volumes of blood from patients via a finger prick or venous puncture. The dried blood samples are then transported to laboratories for analysis of various biomarkers, including proteins, metabolites, drugs, and genetic markers, among others.
Key Pointers
- By Application, the newborn screening held the largest revenue share of 24% in 2023 and is expected to grow at a significant CAGR of 3.33% from 2024 to 2033.
- By Application, the forensics segment is expected to expand at the highest CAGR of 4.43% from 2024 to 2033.
- By Card Type, the Whatman 903 segment contributed the largest market share in 2023 and is expected to grow with the fastest CAGR between 2024 to 2033.
- By End-use, the hospitals & clinics segment generated the maximum market share in 2023.
Get a Sample@ https://www.visionresearchreports.com/report/sample/41313
U.S. Dried Blood Spot Collection Cards Market Trends and Innovations
- Advantages of DBS Collection Cards:
- Sample Stability: DBS cards preserve samples at ambient temperatures, reducing the need for cold chain logistics and enhancing sample transportability.
- Cost Efficiency: Lower sample collection and shipping costs compared to traditional venous blood collection methods.
- Minimally Invasive: Fingerstick sampling reduces patient discomfort and improves sample collection compliance, especially in pediatric and remote settings.
- Technological Advancements:
- Improved Assay Sensitivity: Advances in analytical methods (e.g., LC-MS/MS, PCR) enhance sensitivity and specificity of biomarker detection from DBS samples.
- Automation and High-Throughput Systems: Integration of automated DBS sample processing systems and robotics streamlines workflow efficiencies in large-scale testing environments.
Regulatory Landscape and Challenges
- FDA Approval and Compliance: Regulatory oversight by the U.S. Food and Drug Administration (FDA) ensures safety, efficacy, and performance of DBS collection cards and associated analytical methods used for clinical diagnostics and research.
- Standardization and Quality Control: Standardization of DBS collection protocols, sample extraction methods, and analytical techniques is essential for ensuring reproducibility, reliability, and comparability of results across laboratories.
Competitive Landscape and Market Players
- Key Market Players: PerkinElmer, Inc., Filtroxen, Bio-Rad Laboratories, Inc., Neoteryx LLC, and Ahlstrom-Munksjö are among the leading providers of DBS collection cards, offering a range of products tailored to specific applications and customer needs.
- Strategic Initiatives: Strategic collaborations, partnerships, and acquisitions among key players aim to expand product portfolios, enhance technological capabilities, and penetrate emerging markets.
U.S. Dried Blood Spot Collection Cards Market Future Outlook and Growth Opportunities
- Expansion in Infectious Disease Testing: Increasing demand for rapid diagnostic tests for infectious diseases, including HIV, hepatitis, and malaria, presents growth opportunities for DBS collection cards as a convenient sampling method.
- Rise of Personalized Medicine: Growing emphasis on personalized medicine and pharmacogenomics drives adoption of DBS cards for genetic testing and therapeutic drug monitoring, supporting tailored treatment approaches.
- Advancements in Molecular Diagnostics: Integration of DBS with advanced molecular diagnostic technologies (e.g., next-generation sequencing) enables comprehensive genomic profiling and disease stratification, fostering precision medicine initiatives.
Read More@ https://www.heathcareinsights.com/u-s-exosomes-market-trends-applications-and-growth/
U.S. Dried Blood Spot Collection Cards Market Top Companies:
- Whatman plc (Cytiva)
- GE Healthcare
- MilliporeSigma
- QIAGEN LLC
- PerkinElmer
- Roche
- Shimadzu Corporation
- Ahlstrom-Munksjö
- Eastern Business Forms, Inc.
- CENTOGENE N.V.
Recent Market News
- In February 2024, Cytiva and LevitasBio joined forces to offer an advanced single-cell methodology catering to genomics experts in academia and industry alike.
- In January 2024, Cytiva emphasized its capacity and provision of tailored solutions for diagnostic services as needed.
U.S. Dried Blood Spot Collection Cards Market Segmentation:
By Application
- Newborn Screening (NBS)
- Infectious Diseases Testing
- Therapeutic Drug Monitoring
- Forensics
- CRO/Research
- Other Applications
By Card Type
- Whatman 903
- Ahlstrom 226
- FTA
- Others
By End-use
- Hospitals & Clinics
- Diagnostics Centers
- Others
By Country
- West
- Midwest
- Northeast
- Southwest
- Southeast
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/41313
You can place an order or ask any questions, please feel free to contact sales@visionresearchreports.com| +1 650-460-3308